JG
VRTX icon

Jain Global’s Vertex Pharmaceuticals VRTX Stock Holding History

Jain Global’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Sell
4,677
-20,301
-81% -$9.47M 0.01% 673
2025
Q4 		$11.3M Buy
+24,978
New +$10.8M 0.05% 309

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jain Global's VRTX Position: Q1 2026 in Review

Jain Global reduced its Vertex Pharmaceuticals (VRTX) stake by 81% in Q1 2026, selling an estimated $9.47M and leaving 4,677 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #673.

Jain Global first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $11.3M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Jain Global held 4,677 shares of Vertex Pharmaceuticals worth $2.09M as of Q1 2026.
  • Jain Global sold 20,301 Vertex Pharmaceuticals shares in Q1 2026, an estimated $9.47M.
  • Vertex Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q1 2026, its #673 holding.
  • Jain Global first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Vertex Pharmaceuticals position peaked at $11.3M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.